Angioimmunoblastic lymphadenopathy with dysproteinemia: Emphasis on pathogenesis and treatment

Acta Haematologica

Volumn 99, Issue 2, 1998, Pages 57-64

  Sallah, Sabah ^a   Gagnon, Gregory A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IMMUNOGLOBULIN; MESNA; METHOTREXATE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; PROTEIN; VINBLASTINE; VINCRISTINE;

ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; B LYMPHOCYTE; CLINICAL TRIAL; DISEASE ACTIVITY; DYSPROTEINEMIA; EPSTEIN BARR VIRUS; FEVER; HEMOLYTIC ANEMIA; HEPATOSPLENOMEGALY; HODGKIN DISEASE; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; IMMUNOBLASTIC LYMPHADENOPATHY; LYMPHOCYTE CLONE; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT TRANSFORMATION; META ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; RETICULOSIS; REVIEW; SURVIVAL; T LYMPHOCYTE;

ANTINEOPLASTIC AGENTS; CLONE CELLS; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOPHENOTYPING; LYMPH NODES; PREDNISONE; PROGNOSIS;

EID: 0031908466     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040811     Document Type: Review

References (67)

1. Frizzera G, Moran EM, Rappaport H: Angioimmunoblastic lymphadenopathy with dysproteinaemia. Lancet 1974;i:1070-1073.
2. Frizzera G, Moran EM, Rappaport H: Angioimmunoblastic lymphadenopathy: Diagnosis and clinical course. Am J Med 1975;59:803-818.
3. Stensvold K, Brandtzaeg P, Kvaloy S, Seip M, Lie SO: Immunoblastic lymphadenopathy with early onset in two boys: Immunohistochemical study and indication of decreased proportion of circulating T-helper cells. Br J Hematol 1984;56:417-430.
4. Freter CE, Cossmann J: Angioimmunoblastic lymphadenopathy with dysproteinemia. Semin Oncol 1993;20:627-635.
5. Knecht H: Angioimmunoblastic lymphadenopathy: Ten years' experience and state of current knowledge. Semin Hematol 1989;26:208-215.
6. Ganesan TS, Dhaliwal HS, Dorreen MS, Stansfeld AG, Habeshaw JA, Lister TA: Angioimmunoblastic lymphadenopathy: A clinical, immunological and molecular study. Br J Cancer 1987;55:437-442.
7. Pangalis GA, Moran EM, Rappaport H: Blood and bone marrow findings in angoimmunoblastic lymphadenopathy. Blood 1978;51:71-83.
8. Lynch JW, Elfenbein GJ, Noyes WD, Braylan RC, Gross MA, Weiner RS: Pure red cell aplasia associated with angioimmunoblastic lymphadenopathy with dysproteinemia. Am J Hematol 1994;46:72-78.
9. Offit K, Macris NT, Finkbeinger JA: Monoclonal hypergammaglobulinemia without malignant transformation in angioimmunoblastic lymphadenopathy with dysproteinemia. Am J Med 1986;80:292-294.
10. Lukes RJ, Tindle BH: Immunoblastic lymphadenopathy: A hyperimmune entity resembling Hodgkin's disease. N Engl J Med 1975; 292:1-8.
11. Ironside P, Cornell FN: Immunoblastic lymphadenopathy: A clinicopathological study of 16 cases. Pathology 1979;11:27-37.
12. Feller AC, Griesser H, Schilling CV, Wacker HH, Dallenbach F, Bartels H, Kuse R, Mak TW, Lennert K: Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am J Pathol 1988;133:549-556.
13. Jaffe ES: Angioimmunoblastic T-cell lymphoma: New insights, but the clinical challenge remains. Ann Oncol 1995;6:631-632.
14. Knecht H, Schwarze EW, Lennert K: Histological, immunohistological and autopsy findings in lymphogranulomatosis X (including angioimmunoblastic lymphadenopathy). Virchows Arch 1985;406:105-124.
15. Weiss LM, Strickler JG, Dorfman RF, Horning SJ, Warnke RA, Sklar J: Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pathol 1986;122: 392-397.
16. Namikawa R, Suchi T, Ueda R, Itoh G, Koike K, Ota K, Takahashi T: Phenotyping of proliferating lymphocytes in angioimmunoblastic lymphadenopathy and related lesions by the double immunoenzymatic staining technique. Am J Pathol 1987;127:279-287.
17. Watanabe S, Sato Y, Shimoyama M, Minato K, Shimosato Y: Immunoblastic lymphadenopathy, angioimmunoblastic lymphadenopathy, and IBL-like T-cell lymphoma. Cancer 1986; 58:2224-2232.
18. Ohshima K, Kikuchi M, Hashimoto M, Kozuru M, Uike N, Kobari S, Masuda Y, Sumiyoshi Y, Yoneda S, Takeshita M, Kimura N: Genetic changes in atypical hyperplasia and lymphoma with angioimmunoblastic lymphadenopathy and dysproteinaemia in the same patients. Virchows Arch 1994;425:25-32.
19. Nakamura S, Suchi T: A clinicopathologic study of node-based, low-grade, peripheral T-cell lymphoma. Cancer 1991;67:2565-2578.
20. Takagi N, Nakamura S, Ueda R, Osada H, Obata Y, Kitoh K, Suchi T, Takahashi T: A phenotype and genotypic study of three node-based, low-grade peripheral T-cell lymphomas: Angioimmunoblastic lymphoma, T-zone lymphoma, and lymphoepithelioid lymphoma. Cancer 1992;69:2571-2582.
21. Nathwani BN, Rappaport H, Moran EM, Pangalis GA, Kim H: Malignant lymphoma arising in angio-immunoblastic lymphadenopathy. Cancer 1978;41:578-606.
22. Watanabe S: Pathology of peripheral T-cell lymphomas and leukemias. Hematol Oncol 1986;4:45-58.
23. Tobinia K, Minato K, Ohtsu T, Mukai K, Kagami Y, Miwa M, Watanabe S, Shimoyama M: Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma. Blood 1988;72:1000-1006.
24. Suchi T, Lennert K, Tu LY, Kikuchi M, Sato E, Stansfeld AG, Feller AC: Histopathology and immunohistochemistry of peripheral T cell lymphomas: A proposal for their classification. J Clin Pathol 1987;40:995-1015.
25. Tobinia K, Minato K, Ohtsu T, Mukai K, Kagami Y, Miwa M, Watanabe S, Shimoyama M: Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma. Blood 1988;72:1000-1006.
26. O'Connor NTJ, Crick JA, Wainscoat JS, Gatter KC, Stein H, Falini B, Mason DY: Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy. J Clin Pathol 1986;39:1229-1232.
27. Lipford EH, Smith HR, Pittaluga S, Jaffe ES, Steinberg AD, Cossman J: Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma. J Clin Invest 1987;79:637-642.
28. Knecht H, Odermatt BF, Hayoz D, Kühn L, Bachmann F: Polyclonal rearrangements of the T-cell receptor β-chain in fatal angioimmunoblastic lymphadenopathy. Br J Haematol 1989; 73:491-496.
29. Freter CE, Cossmann J: Angioimmunoblastic lymphadenopathy with dysproteinemia. Semin Oncol 1993;20:627-635.
30. Lorenzen J, Li G, Zhao-Höhn M, Wintzer C, Fischer R, Hansmann ML: Angioimmunoblastic lymphadenopathy type of T-cell lymphoma and angioimmunoblastic lymphadenopathy: A clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin-embedded tissues. Virchows Arch 1994;424:593-600.
31. Araki A, Taniguchi M, Mikata A: T cell receptor Vβ repertoires of angioimmunoblastic lymphadenopathy-like T cell lymphoma. Leuk Lymphoma 1994;16:135-140.
32. Abruzzo L, Schmidt K, Weiss LM, Jaffe ES, Medeiros LJ, Sander CA, Raffeld M: B-cell lymphoma after angioimmunoblastic lymphadenopathy: A case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood 1993;82:241-246.
33. Frizzera G, Kaneko Y, Sakurai M: Angioimmunoblastic lymphadenopathy and related disorders: A retrospective look in search of definitions. Leukemia 1989;3:1-5.
34. Kaneko Y, Maseki N, Sakurai M, Takayama S, Nanba K, Kikuchi M, Frizzera G: Characteristic karyotypic pattern in T-cell lymphoproliferrative disorders with reactive 'angioimmunoblastic lymphadenopathy with dysproteinemia-type' features. Blood 1988;72:413-421.
35. Schlegelberger B, Feller A, Gödde E, Grote W, Lennert K: Stepwise development of chromosomal abnormalities in angioimmunoblastic lymphadenopathy. Cancer Genet Cytogenet 1990;50:15-29.
36. Schlegelberger B, Zhang Y, Weber-Matthiesen K, Grote W: Detection of aberrant clones in nearly all cases of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined interphase and metaphase cytogenetics. Blood 1994;84:2640-2648.
37. Schlegelberger B, Zwingers T, Hohenadel K, Henne-Bruns D, Schmitz N, Haferlach T, Tirier C, Bartels H, Sonnen R, Kuse R, Grote W: Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. J Clin Oncol 1996;14:593-599.
38. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, de Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 1994;84:1361-1392.
39. Lennert K, Feller A: Histopathology of non-Hodgkin's lymphomas, ed 2. Berlin, Springer, 1992.
40. Honda M, Smith HR, Steinberg AD: Studies of the pathogenesis of angioimmunoblastic lymphadenopathy. J Clin Invest 1985;76:332-340.
41. Foss HD, Anagnostopoulos I, Herbst H, Grebe M, Ziemann K, Hummel M, Stein H: Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1995;85:2862-2869.
42. Yamamura M, Honda M, Yamada Y, Itoyama T, Sohda H, Yubashi T, Momita S, Kamihira S, Ohmoto Y, Tomonaga M: Increased levels of interleukin-6 (IL-6) in serum and spontaneous in vitro production of IL-6 by lymph node mononuclear cells of patients with angio-immunoblastic lymphadenopathy with dysproteinemia (AILD), and clinical effectiveness of cyclosporin A. Leukemia 1996;10:1504-1508.
43. Kozuru M, Hashimoto M, Takahira H, Uike N, Ohoshima K, Takeshita M, Kikuchi M: AILD-like dysplasia transformed in AILD-type T cell lymphoma in an HTLV-1 carrier: Usefulness of interferon-α. Acta Haematol 1996;96: 92-98.
44. Özyilkan Ö, Özyilkan E, Karagöz F, Özdamar Ş, Kandemir B: Hepatitis C virus infection and angioimmunoblastic lymphadenopathy. Am J Gastroenterol 1995;90:1029-1030.
45. Krueger GRF, Begholz M, Bartsch HH, Fisch R, Schauer A: Rubella virus antigen in lymphocytes of patients with angioimmunoblastic lymphadenopathy. J Cancer Res Clin Oncol 1991; 95:87-91.
46. Luppi M, Barozzi P, Maiorana A, Artusi T, Trovato R, Marasca R, Savarin M, Ceccherini-Nelli L, Torelli G: Human Herpesvirus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood 1996;87:3903-3909.
47. Luppi M, Marasca R, Barozzi P, Artusi T, Torelli G: Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffin-embedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Leuk Res 1993;17: 1003-1011.
48. Knecht H, Martius F, Bachmann F, Hoffman T, Zimmermann DR, Rothenberger S, Sandvej K, Wegmann W, Hurwitz N, Odermatt BF, Kummer H, Pallessen G: A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma. Leukemia 1995;9:458-465.
49. Kon S, Sato T, Onodera K, Satoh M, Kikuchi K: Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma. Pathol Res Pract 1993;189:1137-1144.
50. Khan G, Norton AJ, Slavin G: Epstein-Barr virus in angioimmunoblastic T-cell lymphomas. Histopathology 1993;22:145-149.
51. Weiss LM, Jaffe ES, Lui XF, Chen YY, Shibata D, Medeiros JL: Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphomas. Blood 1992;79:1789-1795.
52. Knecht H, Sahli R, Shaw P, Meyer C, Bachmann E, Odermatt BF, Bachmann F: Detection of Epstein-Barr virus DNA by polymerase chain reaction in lymph node biopsies from patients with angioimmunoblastic lymphadenopathy. Br J Haematol 1990;75:610-614.
53. Rho R, Laddis T, McQuain C, Selves J, Woda B, Knecht H: Miliary tuberculosis in a patient with Epstein-Barr virus-associated angioimmunoblastic lymphadenopathy. Ann Hematol 1996;72:333-335.
54. Moore PS, Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995;332:1181-1185.
55. Siegert W, Agthe A, Griesser H, Schwerdtfeger R, Brittinger G, Engelhard M, Kuse R, Tiemann M, Lennert K, Huhn D: Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. Ann Intern Med 1992;117:364-370.
56. Pangalis GA, Moran EM, Nathwani BN, Zelman RJ, Kim H, Rappaport H: Angioimmunoblastic lymphadenopathy: Long-term follow-up study. Cancer 1983;52:318-321.
57. Siegert W, Nerl C, Meuthen L, Zahen T, Brack N, Lennert K, Huhn D: Recombinant human interferon-alpha in the treatment of angioimmunoblastic lymphadenopathy: Results in 12 patients. Leukemia 1991;5:892-895.
58. Imoto S, Ito M, Nakagawa T: A remarkable effect of alpha-interferon in a case of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) refractory to steroids and combination chemotherapies. Jpn J Clin Hematol 1991;32:681-685.
59. Ong ST: Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine. Blood 1996;88:2354-2355.
60. Sallah AS, Bernard S: Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosine. Ann Hematol 1996;73:295-296.
61. Schmitz N, Prange E, Haferlach T, Sonnen R, Schlegelberger B, Claus S, Loffler H: High-dose chemotherapy and autologous bone marrow transplantation in relapsing angioimmunoblastic lymphadenopathy with dysproteinemia (AILD). Bone Marrow Transplant 1991;8:503-506.
62. Klinman DM, Steinberg AD, Frederick Mushinaki J: Effect of cyclephosphamide therapy in oncogene expression in angioimmunoblastic lymphadenopathy. Lancet 1986;ii:1055-1057.
63. Archimbaud E, Coiffier B, Bryon PA, Vasselon C, Brizard CP, Viala J: Prognostic factors in angioimmunoblastic lymphadenopathy. Cancer 1987;59:208-212.
64. Aozasa K, Ohsawa M, Fujita MQ, Kanayama Y, Tomiaga N, Yonezawa T, Matsubuchi T, Hirata M, Uda H, Kanamoru A, Inada E, Nakayama S: Angioimmunoblastic lymphadenopathy: Review of 44 patients with emphasis on prognostic behavior. Cancer 1989;63:1625-1629.
65. Bamberg M, Donguijsen K, Hoher PG, Holfeld H, Hossfeld DK: Malignant progression of angioimmunoblastic lymphadenopathy. J Cancer Res Clin Oncol 1979;93:255-263.
66. Tosi P, Auteri A, Cintorino M, Pasini FL, Luzi P: Angioimmunoblastic lymphadenopathy with dysproteinemia complicated by Kaposi's sarcoma. Tumori 1979;65:363-371.
67. Cazzola M, Bergamaschi G, Castello A, Del Forno C, Dezza L, Magrini U, Ascari E: Kaposi's sarcoma complicating immunosuppressive therapy for angioimmunoblastic lymphadenopathy with dysproteinemia. Tumori 1982;68: 537-542.